The FDA gave an emergency use authorization for the first saliva-based Covid-19 test developed by RUCDR Infinite Biologics. Now, startups are once again trying their hand at selling test kits.
The agency gave an emergency use authorization to the testing assay, developed by Rutgers University, Spectrum Solutions and Accurate Diagnostic Labs, for collection of samples at home. The saliva-based test was originally authorized last month.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The test, designed at Rutgers University under a partnership with Spectrum Solutions and Accurate Diagnostic Labs, is designed to allow for broader population screening than the current, more prevalent method of nose and throat swabs.